The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase, but then he ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...

Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...

Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

The FDA has form on this issue ... Trelegy – based on corticosteroid fluticasone furoate, LAMA umeclidinium and LABA vilanterol and approved in 2017 – is central to GSK’s efforts to replace ...

The FDA reveals that phenylephrine, a popular decongestant, is no better than a placebo. Discover what this means for your cold remedy.

The Annals of Pharmacotherapy. 2009;43(3):519-527.

After hours: February 4 at 5:14:24 PM EST Loading Chart for DRUG ...

Drugs overstimulate the brain’s reward circuit, producing pleasure or euphoria. With repeated use, the circuit adjusts to the drug’s effect, reducing sensitivity and making it hard to receive other ...